JesusJaimeCaroMD

PubMed

• 7 citations
  Predicting Hospital Resource Use During COVID-19 Surges: A Simple but Flexible Discretely Integrated Condition Event Simulation of Individual Patient-Hospital Trajecto...
  J. Jaime Caro, Jörgen Möller, Vatshalan Santhirapala, Harpreet Gill, Jessica Johnston, Kariem El-Boghdadly, Ramai Santhirapala, Paul Kelly, Alistair McGuire> ;Value in Health. 2021 Nov 1
• 1 citations
  Evaluating Montréal's harm reduction interventions for people who inject drugs: protocol for observational study and cost-effectiveness analysis.
  Dimitra Panagiotoglou, Michal Abrahamowicz, David L. Buckeridge, J. Jaime Caro, Eric Latimer, Mathieu Maheu-Giroux, Erin Strumpf> ;BMJ Open. 2021 Oct 26
• Risk factors in adolescents as predictors of arterial hypertension in adults: Protocol for a systematic review.
  Márcia Gisele Santos da Costa, J. Jaime Caro, Katia Vergetti Bloch> ;Plos One. 2021 Aug 20
• 7 citations
  Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia
  Anuraag R. Kansal, Odette Reifsnider, Sarah Brand, Neil Hawkins, Anna Coughlan, Shujun Li, Lael Cragin, Clark Paramore, Andrew C. Dietz, J. Jaime Caro> ;Journal of Market Access & Health Policy. 2021 Jun 7
• 1 citations
  Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit-Risk Models: The Example of Rotavirus Vaccination in France.
  Hugo Arlegui, Gaëlle Nachbaur, Nicolas Praet, Bernard Bégaud, J. Jaime Caro> ;Clinical Therapeutics. 2020 Sep 25
• 2 citations
  Leveraging DICE (Discretely-Integrated Condition Event) Simulation to Simplify the Design and Implementation of Hybrid Models
  J. Jaime Caro, Ross Maconachie, Michael Woods, Bhash Naidoo, Alistair McGuire> ;Value in Health. 2020 Aug 1
• 2 citations
  Let's Make Sure We Are Doing Authorship Right.
  J. Jaime Caro> ;Value in Health. 2020 May 25
• 13 citations
  Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrex...
  Salah Ghabri, Aymeric Binard, Yves-Marie Pers, Franck Maunoury, J. Jaime Caro> ;Value in Health. 2020 Apr 1
• 49 citations
  Effect of Fresh vs Standard-issue Red Blood Cell Transfusions on Multiple Organ Dysfunction Syndrome in Critically Ill Pediatric Patients: A Randomized Clinical Trial.
  Philip C. Spinella, Marisa Tucci, Dean Fergusson, Jacques Lacroix, Paul C. Hébert, Stéphane Leteurtre, Kenneth B. Schechtman, Allan Doctor, Robert A. Berg, Tina Bockel...> ;JAMA. 2019 Dec 10
• 2 citations
  Improving Transparency in Decision Models: Current Issues and Potential Solutions
  Paul Tappenden, J. Jaime Caro> ;Pharmacoeconomics. 2019 Oct 23
• 11 citations
  Novel Approaches to Value Assessment Beyond the Cost-Effectiveness Framework.
  Shelby D. Reed, Robert W. Dubois, F. Reed Johnson, J. Jaime Caro, Charles E. Phelps> ;Value in Health. 2019 Jun 1
• 13 citations
  Determining Value in Health Technology Assessment: Stay the Course or Tack Away?
  J. Jaime Caro, John Brazier, Jonathan Karnon, Peter L. Kolominsky-Rabas, Alistair McGuire, Erik Nord, Michael Schlander> ;Pharmacoeconomics. 2019 Mar 1
• 11 citations
  Trusting the Results of Model-Based Economic Analyses: Is there a Pragmatic Validation Solution?
  Salah Ghabri, Mark Stevenson, Jörgen Möller, J. Jaime Caro> ;Pharmacoeconomics. 2019 Jan 1
• 7 citations
  The age of blood in pediatric intensive care units (ABC PICU): study protocol for a randomized controlled trial
  Marisa Tucci, Jacques Lacroix, Dean Fergusson, Allan Doctor, Paul C. Hébert, Robert A. Berg, J. Jaime Caro, Cassandra D. Josephson, Stéphane Leteurtre, Kusum Menon, Ke...> ;Trials. 2018 Jul 28
• 11 citations
  PATIENT-CENTERED DECISION MAKING: LESSONS FROM MULTI-CRITERIA DECISION ANALYSIS FOR QUANTIFYING PATIENT PREFERENCES.
  Kevin Marsh, J. Jaime Caro, Erica Zaiser, James Heywood, Alaa Hamed> ;International Journal of Technology Assessment in Health Care. 2017 Dec 26
• 55 citations
  The Use of MCDA in HTA: Great Potential, but More Effort Needed
  Kevin Marsh, Mark Sculpher, J. Jaime Caro, Tommi Tervonen> ;Value in Health. 2017 Nov 21
• 6 citations
  Adding Events to a Markov Model Using DICE Simulation.
  J. Jaime Caro, Jörgen Möller> ;Medical Decision Making. 2017 Jul 5
• 8 citations
  Validation of a DICE Simulation Against a Discrete Event Simulation Implemented Entirely in Code.
  Jörgen Möller, Sarah Davis, Mark Stevenson, J. Jaime Caro> ;Pharmacoeconomics. 2017 Jul 1
• 7 citations
  Comparative Effectiveness of Tacrolimus-Based Steroid Sparing versus Steroid Maintenance Regimens in Kidney Transplantation: Results from Discrete Event Simulation:
  Vibha C. A. Desai, Yann Ferrand, Teresa M. Cavanaugh, Christina M.L. Kelton, J. Jaime Caro, Jens Goebel, Pamela C. Heaton> ;Medical Decision Making. 2017 Apr 6
• 30 citations
  Amplifying Each Patient's Voice: A Systematic Review of Multi-criteria Decision Analyses Involving Patients.
  Kevin Marsh, J. Jaime Caro, Alaa Hamed, Erica Zaiser> ;Applied Health Economics and Health Policy. 2017 Apr 1
• Pharmacoeconomics, Outcomes Research, Health Technology Assessment, Comparative Effectiveness, Patient Centered Outcomes Research in Latin America 2016: brief update.
  Federico Augustovski, J. Jaime Caro, Marcos Bosi Ferraz, Victor Zárate> ;Value in Health Regional Issues. 2016 Dec 1
• Reply: Letter to the Editor: About the advantages and disadvantages of discrete-event simulation for health economic analyses.
  J. Jaime Caro, Jörgen Möller> ;Expert Review of Pharmacoeconomics & Outcomes Research. 2016 Nov 25
• 2 citations
  Model-observational bridging study on the effectiveness of ezetimibe on cardiovascular morbidity and mortality in France: A population-based study
  Jean Ferrières, Jean Dallongeville, Michel Rossignol, Jacques Bénichou, J. Jaime Caro, Denis Getsios, Luis Hernandez, Lucien Abenhaim, Lamiae Grimaldi-Bensouda> ;Journal of Clinical Lipidology. 2016 Nov 1
• 1 citations
  Response to Letter to the Editor Regarding Discretely Integrated Condition Event Simulation for Pharmacoeconomics.
  J. Jaime Caro> ;Pharmacoeconomics. 2016 Nov 1
• 23 citations
  Advantages and disadvantages of discrete-event simulation for health economic analyses.
  J. Jaime Caro, Jörgen Möller> ;Expert Review of Pharmacoeconomics & Outcomes Research. 2016 Mar 25
• Join now to see all